Clinical Trial Update: Nucleosides And Darunavir/Dolutegravir In Africa [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update involving nucleosides and darunavir/dolutegravir for HIV in Africa.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Aids

Drugs mentioned

• darunavir/dolutegravir

Snippet

Sponsor: Makerere University | Conditions: Human Immunodeficiency Virus | Phase 3 | Status: UNKNOWN